+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab



Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab



Haematologica 88(6): Ecr22




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049117767

Download citation: RISBibTeXText

PMID: 12801855


Related references

Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leukemia and Lymphoma 45(3): 627-629, 2004

Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients. Cancer 92(11): 2927-2932, 2001

Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab. Medicina Clinica 127(1): 39, 2006

Fatal Fulminant Hepatitis from Rituximab-induced Hepatitis B Reactivation in a Patient with Follicular Lymphoma: A Case Report and a Brief Review of Literature. Cureus 10(3): E2257, 2018

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chinese Journal of Cancer 34(5): 225-234, 2015

Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B. Korean Journal of Gastroenterology 55(4): 266-269, 2010

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Digestive Diseases and Sciences 37(8): 1253-1259, 1992

Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab). 2007

Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy. Supportive Care in Cancer 21(5): 1265-1271, 2013

Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab. Leukemia and Lymphoma 48(2): 431-433, 2007

Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. Journal of Clinical Oncology 32(33): 3736-3743, 2014

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy. Leukemia and Lymphoma 56(4): 1027-1032, 2015

Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab. Revista Espanola de Quimioterapia 28(1): 56-57, 2015

Reactivation of hepatitis B virus in a patient treated for non-Hodgkin B diffuse large cell lymphoma with rituximab: about a case. Pan African Medical Journal 22: 22, 2015

Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma. Annals of Internal Medicine 150(9): 655-656, 2009